Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction

Abstract Background Left ventricular thrombosis (LVT) after acute ST-segment elevation myocardial infarction (STEMI) is closely related to inflammation. Soluble Suppression of Tumorigenicity 2 (sST2) expressed as a novel inflammatory marker, has received much attention in recent years. However, the...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinjia Du, Perkash Kumar, Chen Liu, Jiahua Liu, Lei Chen, Yuan Lu, Zhuoqi Zhang
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-025-04667-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849390460445917184
author Xinjia Du
Perkash Kumar
Chen Liu
Jiahua Liu
Lei Chen
Yuan Lu
Zhuoqi Zhang
author_facet Xinjia Du
Perkash Kumar
Chen Liu
Jiahua Liu
Lei Chen
Yuan Lu
Zhuoqi Zhang
author_sort Xinjia Du
collection DOAJ
description Abstract Background Left ventricular thrombosis (LVT) after acute ST-segment elevation myocardial infarction (STEMI) is closely related to inflammation. Soluble Suppression of Tumorigenicity 2 (sST2) expressed as a novel inflammatory marker, has received much attention in recent years. However, the relationship between sST2 and LVT is unclear. This study aimed to investigate the correlation between sST2 and LVT formation after emergency PCI (pPCI) in STEMI patients. Methods 293 patients with STEMI who were tested for sST2 at admission within 24 h at the Affiliated Hospital of Xuzhou Medical University from June 2018 to August 2023 were consecutively enrolled and evaluated for myocardial infarction characteristics and the presence of LVT by cardiac magnetic resonance imaging (CMR). The diagnosis of LVT was defined as a left ventricular cavity in the late gadolinium enhancement (LGE) of CMR with a low signal intensity mass. Results A total of 38 patients developed LVT after STEMI, multivariable logistic regression analysis showed that sST2 [P = 0.002, OR = 1.01 (1.01 ~ 1.02)] an independent predictor of LVT formation. The results of the net reclassification index (NRI) and Integrated Discrimination Improvement Index (IDI) suggested that sST2 could improve the conventional model of LVT. A linear relationship between sST2 and LVT was fitted using a restricted cubic spline (RCS). Conclusion sST2 was independently associated with LVT formation after pPCI in STEMI patients, and sST2 improved the risk modeling of LVT. Clinical trial number Not applicable.
format Article
id doaj-art-4f2e1e187e2947e48c2fe241aa31faf8
institution Kabale University
issn 1471-2261
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj-art-4f2e1e187e2947e48c2fe241aa31faf82025-08-20T03:41:39ZengBMCBMC Cardiovascular Disorders1471-22612025-03-012511910.1186/s12872-025-04667-ySoluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarctionXinjia Du0Perkash Kumar1Chen Liu2Jiahua Liu3Lei Chen4Yuan Lu5Zhuoqi Zhang6Department of Cardiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Cardiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Cardiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Cardiology, Shanghai Tenth People’s Hospital, Tongji University School of MedicineDepartment of Cardiology, Shanghai Tenth People’s Hospital, Tongji University School of MedicineDepartment of Cardiology, The Affiliated Hospital of Xuzhou Medical UniversityDepartment of Cardiology, The Affiliated Hospital of Xuzhou Medical UniversityAbstract Background Left ventricular thrombosis (LVT) after acute ST-segment elevation myocardial infarction (STEMI) is closely related to inflammation. Soluble Suppression of Tumorigenicity 2 (sST2) expressed as a novel inflammatory marker, has received much attention in recent years. However, the relationship between sST2 and LVT is unclear. This study aimed to investigate the correlation between sST2 and LVT formation after emergency PCI (pPCI) in STEMI patients. Methods 293 patients with STEMI who were tested for sST2 at admission within 24 h at the Affiliated Hospital of Xuzhou Medical University from June 2018 to August 2023 were consecutively enrolled and evaluated for myocardial infarction characteristics and the presence of LVT by cardiac magnetic resonance imaging (CMR). The diagnosis of LVT was defined as a left ventricular cavity in the late gadolinium enhancement (LGE) of CMR with a low signal intensity mass. Results A total of 38 patients developed LVT after STEMI, multivariable logistic regression analysis showed that sST2 [P = 0.002, OR = 1.01 (1.01 ~ 1.02)] an independent predictor of LVT formation. The results of the net reclassification index (NRI) and Integrated Discrimination Improvement Index (IDI) suggested that sST2 could improve the conventional model of LVT. A linear relationship between sST2 and LVT was fitted using a restricted cubic spline (RCS). Conclusion sST2 was independently associated with LVT formation after pPCI in STEMI patients, and sST2 improved the risk modeling of LVT. Clinical trial number Not applicable.https://doi.org/10.1186/s12872-025-04667-yLeft ventricular thrombosisSoluble suppression of tumorigenicity 2Cardiovascular magnetic resonanceMyocardial infarctionPrognosis
spellingShingle Xinjia Du
Perkash Kumar
Chen Liu
Jiahua Liu
Lei Chen
Yuan Lu
Zhuoqi Zhang
Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction
BMC Cardiovascular Disorders
Left ventricular thrombosis
Soluble suppression of tumorigenicity 2
Cardiovascular magnetic resonance
Myocardial infarction
Prognosis
title Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction
title_full Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction
title_fullStr Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction
title_full_unstemmed Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction
title_short Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction
title_sort soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with st segment elevation myocardial infarction
topic Left ventricular thrombosis
Soluble suppression of tumorigenicity 2
Cardiovascular magnetic resonance
Myocardial infarction
Prognosis
url https://doi.org/10.1186/s12872-025-04667-y
work_keys_str_mv AT xinjiadu solublesuppressionoftumorigenicity2associatedwithleftventricularthrombosisinpatientswithstsegmentelevationmyocardialinfarction
AT perkashkumar solublesuppressionoftumorigenicity2associatedwithleftventricularthrombosisinpatientswithstsegmentelevationmyocardialinfarction
AT chenliu solublesuppressionoftumorigenicity2associatedwithleftventricularthrombosisinpatientswithstsegmentelevationmyocardialinfarction
AT jiahualiu solublesuppressionoftumorigenicity2associatedwithleftventricularthrombosisinpatientswithstsegmentelevationmyocardialinfarction
AT leichen solublesuppressionoftumorigenicity2associatedwithleftventricularthrombosisinpatientswithstsegmentelevationmyocardialinfarction
AT yuanlu solublesuppressionoftumorigenicity2associatedwithleftventricularthrombosisinpatientswithstsegmentelevationmyocardialinfarction
AT zhuoqizhang solublesuppressionoftumorigenicity2associatedwithleftventricularthrombosisinpatientswithstsegmentelevationmyocardialinfarction